DuChemBio(176750) hit the daily upper limit (the top of the daily price band) right after the open on the 24th. It is seen as driven by news that the U.S. Food and Drug Administration (FDA) completed active pharmaceutical ingredient registration for the main raw material of a Parkinson's disease diagnostic.
As of 9:09 a.m. that day, DuChemBio shares were trading on the KOSDAQ market at 7,310 won, up 29.84% (1,680 won) from the previous session. DuChemBio shares hit the upper limit right after the open.
DuChemBio said that on the morning of the day it completed FDA drug master file (DMF) registration for the main raw material of the Parkinson's disease diagnostic "18F-FP-CIT," securing the raw material requirements needed for North American supply.
For entry into the U.S. market, FDA registration of pharmaceutical ingredients is considered an essential step.